CDEK
← All drugs Report issue

ibi112

mAbexperimental

Clinical trial activity

6 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
5
Phase 3
3
Phase 4
0

Earliest trial started Aug 27, 2020 (NCT04511624)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07265284Phase 3Dec 31, 2025Innovent Biologics (Suzhou) Co. Ltd.
NCT06049810Phase 3Oct 12, 2023Innovent Biologics (Suzhou) Co. Ltd.
NCT05645627Phase 3Dec 30, 2022Innovent Biologics (Suzhou) Co. Ltd.
NCT05377580Phase 2Jul 1, 2022Innovent Biologics (Suzhou) Co. Ltd.
NCT05003531Phase 2Sep 23, 2021Innovent Biologics (Suzhou) Co. Ltd.
NCT04511624Phase 1Aug 27, 2020Innovent Biologics (Suzhou) Co. Ltd.
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Innovent Biologics (Suzhou) Co. Ltd.For profit6632020
1 organizations
Page 1 / 1